Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
5(71%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
29%
Ph phase_2
2
29%
Ph phase_4
1
14%
Ph phase_3
1
14%

Phase Distribution

0

Early Stage

2

Mid Stage

2

Late Stage

Phase Distribution6 total trials
Phase 2Efficacy & side effects
2(33.3%)
Phase 3Large-scale testing
1(16.7%)
Phase 4Post-market surveillance
1(16.7%)
N/ANon-phased studies
2(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

5

trials recruiting

Total Trials

7

all time

Status Distribution
Active(6)
Completed(1)

Detailed Status

Recruiting4
Completed1
Active, not recruiting1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
5
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (33.3%)
Phase 31 (16.7%)
Phase 41 (16.7%)
N/A2 (33.3%)

Trials by Status

recruiting457%
completed114%
active_not_recruiting114%
not_yet_recruiting114%

Recent Activity

5 active trials
Showing 5 of 7
not_yet_recruitingnot_applicable

Clinical Study on the Preservation of Ovarian Function Following Autologous Hematopoietic Stem Cell Transplantation Using Goserelin

NCT07552493
recruitingphase_4

Adaptions and Resiliency to Multi-Stressor OpeRations

NCT06455969
recruitingphase_2

Impact of Omitting Chemo Based on Patient's Selection for ER-Positive, HER2-Negative Breast Cancer With Ribociclib and Endocrine Therapy

NCT06953882
active_not_recruiting

Study of Preservation of Ovarian Reserve During Chemotherapy for Young Breast Cancer Patients

NCT02430103
recruitingphase_2

Neoadjuvant Therapy of Darolutamide Plus ADT for High Risk Prostate Cancer

NCT06575257
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT07552493Not Applicable

Clinical Study on the Preservation of Ovarian Function Following Autologous Hematopoietic Stem Cell Transplantation Using Goserelin

Not Yet Recruiting
NCT06455969Phase 4

Adaptions and Resiliency to Multi-Stressor OpeRations

Recruiting
NCT06953882Phase 2

Impact of Omitting Chemo Based on Patient's Selection for ER-Positive, HER2-Negative Breast Cancer With Ribociclib and Endocrine Therapy

Recruiting
NCT02430103

Study of Preservation of Ovarian Reserve During Chemotherapy for Young Breast Cancer Patients

Active Not Recruiting
NCT06575257Phase 2

Neoadjuvant Therapy of Darolutamide Plus ADT for High Risk Prostate Cancer

Recruiting
NCT03447132Phase 3

Fulvestrant Versus Fulvestrant Plus Palbociclib in Operable Breast Cancer Responding to Fulvestrant

Completed
NCT04894188Not Applicable

Neoadjuvant Hormone and Radiation Therapy Followed by Radical Prostatectomy in Patients With High-Risk Prostate Cancer

Recruiting

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7